Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-03-08 5:1:22 am | Ocuphire Pharma Announces Financial Results for Fourth Quarter and Full Year 2023 and Provides Corporate Update | GlobeNewsWire |
| 2024-02-23 5:0:0 am | Ocuphire Pharma to Present in the BIO CEO & Investor Conference | GlobeNewswire |
| 2024-02-15 1:10:0 pm | Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | GlobeNewswire |
| 2024-02-14 5:0:0 am | Ocuphire Pharma Strengthens Leadership Team with Key Appointments | GlobeNewswire |
| 2024-02-05 5:0:0 am | Ocuphire Pharma Announces Presentation on APX3330 at the Annual Angiogenesis, Exudation, and Degeneration 2024 Conference | GlobeNewswire |
| 2024-01-04 5:0:0 am | Ocuphire Pharma Receives FDA Agreement Under Special Protocol Assessment for LYNX-2 Phase 3 Trial of Phentolamine Ophthalmic Solution for the Treatment of Decreased Visual Acuity under Dim (mesopic) Light Conditions | GlobeNewswire |
Please consider a small donation if you think this website provides you with relevant information